恒瑞医药

- 600276

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
单位:元
恒瑞医药(600276) 财务指标
报告期2008-06-302008-03-312007-12-312007-09-302007-06-30
每股财务数据
每股收益(元)0.37080.17230.95790.57870.3567
每股收益增长率(%)3.96251.183553.706822.9953-15.3818
每股收益-扣除(元)0.49020.17230.95160.57470.3564
每股收益-扣除-增长率(%)37.5421062.389122.3807-15.1429
每股收益-加权(元)0.37080.17230.95790.57870.3567
每股收益-加权-增长率(%)3.95291.174453.7560-15.4739
每股收益-扣除/加权(元)0.49020.17230.95160.57470.3564
每股收益-扣除/加权-增长率(%)37.5421062.38910-15.1429
每股未分配利润(元)1.39331.70891.53661.25371.0317
每股可分配利润(元)00000
每股净资产(元)3.3983.923.7483.3693.15
每股净资产增长率(%)7.985732.4236-0.214-6.5088-29.9811
每股净资产-调整(元)00000
每股现金含量(元)0.1690.140.5080.70.4769
每股资本公积金(元)0.61030.7380.7380.7380.738
每股盈余公积金(元)0.39460.47350.47350.37720.3772
每股负债比(%)51.469565.853988.270279.543664.2625
偿债能力分析
流动比率5.71625.28184.21083.79864.0976
速动比率5.27544.85443.88653.45213.7411
现金流动负债比(%)32.851621.944961.65389.024174.8214
股东权益比(%)85.898184.777880.23680.041782.3181
流动负债率(%)99.702698.288893.298798.985599.1753
负债权益比(%)15.146116.797623.550623.611120.4209
经营效率分析
存货周转天(天)94.692112.4859116.2528122.9844112.7113
存货周转率(倍)1.90090.80013.09672.19541.597
应收款周转天(天)72.167470.126252.215538.51734.9257
应收帐款周转率(倍)2.49421.28346.89457.00995.1538
主营成本比例(%)18.424715.667216.858717.080917.4036
营业费用比例(%)41.058937.860640.726238.592141.5953
管理费用比例(%)10.039813.998220.729619.110219.4466
财务费用比例(%)0.38260.40550.19910.06580.0219
总资产周转率(倍)0.58990.29871.12890.84780.5796
盈利能力分析
经营净利率(%)16.018412.412521.071117.98417.0811
经营毛利率(%)80.003982.681381.550881.318580.9853
资产利润率(%)12.59195.098329.464820.875312.0909
资产净利率(%)9.44893.707823.788115.24669.9009
净利润率(%)16.018412.412521.071117.98417.0811
净资产收益率(%)10.914.425.5617.1811.33
净资产收益率-增长率(%)-3.7257-23.59154.036431.558220.8506
净资产收益率-扣除(%)14.434.425.3917.0611.33
净资产收益率-扣除-增长率(%)27.361-23.344962.860830.928621.3062
净资产收益率-加权(%)11.1028.23011.54
净资产收益率-加权-增长率(%)-3.8128060.4889023.2906
净资产收益率-扣除/加权(%)14.68028.05011.53
净资产收益率-扣除/加权-增长率(%)27.32069.6915023.7124
税前利润增长率(%)36.1396-6.772276.794960.285233.7077
扣除非经常性损益后净利润253588252.4674287870.88410199275.31247726466.6153640721.86
成长能力分析
主营收入增长率(%)33.031348.911637.765933.450834.1796
净利润增长率(%)24.75491.183599.818959.893943.0048
总资产增长率(%)24.182125.868838.115828.772419.4935
股东权益增长率(%)29.582832.423629.721921.538518.3319
主营利润增长率(%)31.419247.970940.988635.471436.1628
财务结构分析
资产负债率(%)13.010214.240618.896118.898716.8101
长期负债资产比(%)00000
固定比(%)25.079525.391824.893827.992830.6441
现金流量比率
主营收入现金含量(倍)1.01380.99410.96331.03931.0469
净利润现金含量(倍)0.45460.82420.53011.21131.3369
恒瑞医药(600276) 财务指标
报告期2007-03-312006-12-312006-09-302006-06-302006-03-31
每股财务数据
每股收益(元)0.17030.6230.4710.4220.201
每股收益增长率(%)-15.288-2.011-7.598640.812728.8074
每股收益-扣除(元)--0.5860.46960.42--
每股收益-扣除-增长率(%)---8.0063--40.4682--
每股收益-加权(元)0.17030.623--0.422--
每股收益-加权-增长率(%)---2.044--41.1371--
每股收益-扣除/加权(元)--0.586--0.42--
每股收益-扣除/加权-增长率(%)---8.0063--40.4682--
每股未分配利润(元)0.84531.30591.21561.39011.1696
每股可分配利润(元)--1.4752--1.61011.1696
每股净资产(元)2.993.7563.64.4944.49
每股净资产增长率(%)-34.121-12.502-13.504213.602917.859
每股净资产-调整(元)--3.7563.594.4944.47
每股现金含量(元)0.22470.80270.62560.39910.1753
每股资本公积金(元)0.7380.95990.95991.54781.5478
每股盈余公积金(元)0.37720.49030.4280.55640.5564
每股负债比(%)68.447660.638661.060586.452477.4992
偿债能力分析
流动比率4.37186.70886.37485.50615.9987
速动比率3.95086.01145.8165.00685.5601
现金流动负债比(%)39.2033188.9738141.398861.724131.2026
股东权益比(%)80.581485.427884.805783.126184.54
流动负债率(%)83.73270.050472.464374.785472.4744
负债权益比(%)23.120116.143916.94519.235817.2455
经营效率分析
存货周转天(天)149.5513112.8491106.9603108.840298.1461
存货周转率(倍)0.60183.19012.52431.65380.917
应收款周转天(天)34.275337.49837.954440.311743.1014
应收帐款周转率(倍)2.62589.60057.11384.46522.0881
主营成本比例(%)15.142218.723918.302818.62318.0905
营业费用比例(%)37.822939.548338.551438.765938.0092
管理费用比例(%)18.350221.152321.265120.212919.3429
财务费用比例(%)-0.2992-0.0374-0.1569-0.0164-0.1655
总资产周转率(倍)0.26431.03710.77160.50360.2525
盈利能力分析
经营净利率(%)18.267414.527515.009816.026915.3782
经营毛利率(%)83.206979.686780.105679.805780.3124
资产利润率(%)7.204321.091915.818710.54165.8824
资产净利率(%)4.827515.066311.58178.0713.8835
净利润率(%)18.267414.527515.009816.026915.3782
净资产收益率(%)5.7416.5913.069.384.47
净资产收益率-增长率(%)28.587111.996.827623.95179.2894
净资产收益率-扣除(%)5.7415.5913.039.344.47
净资产收益率-扣除-增长率(%)28.41165.05396.628523.381820.1613
净资产收益率-加权(%)--17.59--9.36--
净资产收益率-加权-增长率(%)--12.6842--25.3012--
净资产收益率-扣除/加权(%)--16.53--9.32--
净资产收益率-扣除/加权-增长率(%)--5.6905--24.7657--
税前利润增长率(%)41.048231.078522.118221.590523.0656
扣除非经常性损益后净利润--194212218.36155727484.91107034210.04--
成长能力分析
主营收入增长率(%)20.520420.622918.508816.033214.8151
净利润增长率(%)43.163227.385820.121840.812728.8074
总资产增长率(%)16.80513.441912.824913.54147.5533
股东权益增长率(%)11.335613.747412.444513.602917.859
主营利润增长率(%)24.86421.860916.756113.72178.9354
财务结构分析
资产负债率(%)18.630513.791314.370315.9914.5793
长期负债资产比(%)3.03084.13053.9574.03184.013
固定比(%)30.8459--33.298133.831436.2855
现金流量比率
主营收入现金含量(倍)1.06371.17791.16251.18151.1438
净利润现金含量(倍)1.31921.28811.32970.94670.8717
恒瑞医药(600276) 财务指标
报告期2005-12-312005-09-302005-06-302005-03-312004-12-31
每股财务数据
每股收益(元)0.6360.50920.2990.1560.481
每股收益增长率(%)32.29643.216448.537928.640529.7297
每股收益-扣除(元)0.637--0.2990.14190.473
每股收益-扣除-增长率(%)34.6723--21.544716.982742.042
每股收益-加权(元)0.636--0.299--0.481
每股收益-加权-增长率(%)32.2245--48.0198--29.6496
每股收益-扣除/加权(元)0.637--0.299--0.473
每股收益-扣除/加权-增长率(%)34.6723--21.5447--42.042
每股未分配利润(元)0.96861.1890.97910.83590.8798
每股可分配利润(元)1.3886--1.1791--0.9798
每股净资产(元)4.294.173.9563.8133.857
每股净资产增长率(%)11.304211.640410.58095.989810.9527
每股净资产-调整(元)4.274.163.9463.7883.831
每股现金含量(元)0.89340.70350.5480.08740.821
每股资本公积金(元)1.54781.54781.54781.54781.5478
每股盈余公积金(元)0.55640.42920.42920.42920.4292
每股负债比(%)69.432867.495675.5535107.9559100.8849
偿债能力分析
流动比率6.52486.4414.06322.9123.1969
速动比率5.96455.95773.74342.66792.9305
现金流动负债比(%)185.7312150.047977.95568.494988.2373
股东权益比(%)85.198385.092683.081277.147778.3645
流动负债率(%)69.276669.468293.039495.27992.2279
负债权益比(%)16.174116.201419.097528.313126.1573
经营效率分析
存货周转天(天)103.3176109.4669111.0494144.4159110.6875
存货周转率(倍)3.48442.46651.62090.62323.2524
应收款周转天(天)47.590751.839351.260152.234560.1896
应收帐款周转率(倍)7.56455.20843.51151.7235.9811
主营成本比例(%)19.49617.017716.898913.653225.0029
营业费用比例(%)40.363944.541144.943246.304337.6094
管理费用比例(%)20.323217.678817.832518.526519.7922
财务费用比例(%)-0.0067-0.0408-0.0406-0.01660.8624
总资产周转率(倍)0.92830.70050.46810.23090.8464
盈利能力分析
经营净利率(%)13.756314.808313.206613.707710.7079
经营毛利率(%)78.877181.308181.427984.647173.4642
资产利润率(%)17.374213.93649.35185.017512.7607
资产净利率(%)12.770410.37316.18263.16489.0626
净利润率(%)13.756314.808313.206613.707710.7079
净资产收益率(%)14.8212.227.574.0912.46
净资产收益率-增长率(%)18.859928.283634.325121.370616.9234
净资产收益率-扣除(%)14.8412.227.573.7212.27
净资产收益率-扣除-增长率(%)20.945428.767110.834610.385827.9458
净资产收益率-加权(%)15.61--7.47--12.94
净资产收益率-加权-增长率(%)20.6337--32.6821--18.3898
净资产收益率-扣除/加权(%)15.64--7.47--12.73
净资产收益率-扣除/加权-增长率(%)22.8594--9.3704--29.5015
税前利润增长率(%)27.827948.015763.720637.002514.5739
扣除非经常性损益后净利润162533883.38--76355047.6936195998.8120720776.83
成长能力分析
主营收入增长率(%)2.9792-1.648812.35618.4979.0247
净利润增长率(%)32.29643.216448.537928.640529.7297
总资产增长率(%)2.37647.2831-2.8327-4.8063-13.4629
股东权益增长率(%)11.304211.640410.58095.989810.9527
主营利润增长率(%)10.56688.055912.267423.839222.1405
财务结构分析
资产负债率(%)13.780113.786215.866421.842920.4981
长期负债资产比(%)4.23374.20921.10441.03121.5931
固定比(%)37.363237.955739.650439.040239.2049
现金流量比率
主营收入现金含量(倍)1.18411.18081.18761.11421.1614
净利润现金含量(倍)1.40471.38171.83060.55981.7078
恒瑞医药(600276) 财务指标
报告期2004-09-302004-06-302004-03-312003-12-312003-09-30
每股财务数据
每股收益(元)0.3560.2020.1210.3710.241
每股收益增长率(%)47.504144.793837.210519.7153-0.7344
每股收益-扣除(元)0.3540.2460.12130.3330.241
每股收益-扣除-增长率(%)46.88876.9784016.84217.5893
每股收益-加权(元)--0.202--0.371--
每股收益-加权-增长率(%)045.3237019.67740
每股收益-扣除/加权(元)--0.246--0.333--
每股收益-扣除/加权-增长率(%)076.9784016.84210
每股未分配利润(元)0.85080.69670.71650.58770.5334
每股可分配利润(元)--0.7967--0.68770.5334
每股净资产(元)3.7323.5783.5983.4763.347
每股净资产增长率(%)11.506210.265312.637711.93796.4514
每股净资产-调整(元)3.7083.5323.5433.3423.295
每股现金含量(元)0.47490.38870.14330.5360.2659
每股资本公积金(元)1.54781.54781.54781.54781.5478
每股盈余公积金(元)0.33310.33310.33310.34060.2654
每股负债比(%)76.1296126.218153.9752214.5816215.872
偿债能力分析
流动比率4.74233.34842.79361.69761.7101
速动比率4.19672.93932.46261.43721.4522
现金流动负债比(%)83.441943.491612.748331.573616.0683
股东权益比(%)81.771573.003369.289561.120160.0594
流动负债率(%)74.766470.802673.010779.171976.6631
负债权益比(%)20.40135.279642.801161.730264.505
经营效率分析
存货周转天(天)118.7544213.2449218.6058107.8555104.9033
存货周转率(倍)2.27360.84410.41173.33782.5738
应收款周转天(天)57.864267.608271.559275.574779.158
应收帐款周转率(倍)4.66612.66241.25774.76353.4109
主营成本比例(%)24.480716.904117.446333.150234.6125
营业费用比例(%)44.131445.87344.896632.356731.9677
管理费用比例(%)15.689418.809315.731718.883818.1658
财务费用比例(%)0.80761.10421.19611.60831.615
总资产周转率(倍)0.68210.38110.17670.79110.5795
盈利能力分析
经营净利率(%)10.16939.989612.62688.99898.0804
经营毛利率(%)74.005781.492180.995665.575464.1205
资产利润率(%)9.01755.22413.320611.35077.4018
资产净利率(%)6.93683.80672.23067.11944.6828
净利润率(%)10.16939.989612.62688.99898.0804
净资产收益率(%)9.535.633.3710.667.202
净资产收益率-增长率(%)32.283431.31421.81586.9479-6.7503
净资产收益率-扣除(%)9.496.833.379.597.202
净资产收益率-扣除-增长率(%)31.76959.579421.66064.58020
净资产收益率-加权(%)--5.63--10.93--
净资产收益率-加权-增长率(%)028.538808.32510
净资产收益率-扣除/加权(%)--6.83--9.83--
净资产收益率-扣除/加权-增长率(%)055.936105.9267-100
税前利润增长率(%)21.309521.526836.396736.364311.0983
扣除非经常性损益后净利润90301939.1562371363.8530949816.2385011851.7861482138.24
成长能力分析
主营收入增长率(%)17.20493.740910.028338.930839.123
净利润增长率(%)47.504144.793837.210519.7153-0.7344
总资产增长率(%)-18.1011-10.97872.499720.431320.7192
股东权益增长率(%)11.506210.265312.637711.93796.4514
主营利润增长率(%)35.273836.729535.289847.127854.5348
财务结构分析
资产负债率(%)16.682225.755329.656737.729638.7413
长期负债资产比(%)4.20957.51998.00417.85839.041
固定比(%)40.736538.939735.67649.242749.1599
现金流量比率
主营收入现金含量(倍)1.15581.13331.13431.17411.1572
净利润现金含量(倍)1.33581.92861.18111.44751.1032
恒瑞医药(600276) 财务指标
报告期2003-06-302003-03-312002-12-312002-09-302002-06-30
每股财务数据
每股收益(元)0.1390.0880.310.2430.185
每股收益增长率(%)-24.5643.148-18.92680-8.4638
每股收益-扣除(元)0.139--0.2850.2240.165
每股收益-扣除-增长率(%)-15.75760-3.71620-11.7647
每股收益-加权(元)0.139--0.31--0.185
每股收益-加权-增长率(%)-24.86490-18.84820-8.4158
每股收益-扣除/加权(元)0.139--0.285--0.165
每股收益-扣除/加权-增长率(%)-15.75760-3.71620-11.7647
每股未分配利润(元)0.43140.3810.29220.3920.3338
每股可分配利润(元)0.4314--0.5589--0.5005
每股净资产(元)3.2453.1943.1053.1443.085
每股净资产增长率(%)5.1571-10.94-11.16710-8.0518
每股净资产-调整(元)3.1873.1323.0433.0973.032
每股现金含量(元)0.06630.0050.195--0.0541
每股资本公积金(元)1.54781.5481.54781.5531.5529
每股盈余公积金(元)0.26540.2650.26540.1990.1987
每股负债比(%)220.0076179.668154.7022136.298143.2389
偿债能力分析
流动比率1.68252.0562.05962.6152.6063
速动比率1.43371.7421.74562.3662.2389
现金流动负债比(%)3.82230.41116.3339--5.6216
股东权益比(%)58.938363.05365.757668.10966.7938
流动负债率(%)78.883773.2777.318969.53967.1559
负债权益比(%)67.807756.25549.817243.35546.4238
经营效率分析
存货周转天(天)101.0044123.119115.603286.26299.2775
存货周转率(倍)1.78210.7313.11413.131.8131
应收款周转天(天)81.669788.67100.8234104.97752.4323
应收帐款周转率(倍)2.2041.0153.57062.5723.433
主营成本比例(%)36.995933.01136.850241.01143.8451
营业费用比例(%)29.267734.96130.960524.65621.307
管理费用比例(%)19.597514.22515.510915.47215.1297
财务费用比例(%)1.6451.611.68142.231.7877
总资产周转率(倍)0.38030.1780.65070.4760.3119
盈利能力分析
经营净利率(%)7.157310.12510.443311.32513.1356
经营毛利率(%)61.830665.87261.92257.72654.9275
资产利润率(%)4.45022.7069.51197.6185.6381
资产净利率(%)2.72171.8076.79585.3944.0972
净利润率(%)7.157310.12510.443311.32513.1356
净资产收益率(%)4.292.779.977.7245.98
净资产收益率-增长率(%)-28.263515.819-8.73520-0.448
净资产收益率-扣除(%)4.282.779.17--5.35
净资产收益率-扣除-增长率(%)-2008.26450-3.9497
净资产收益率-加权(%)4.38--10.09--6.14
净资产收益率-加权-增长率(%)-28.66450-11.87770-0.8078
净资产收益率-扣除/加权(%)4.38--9.287.375.5
净资产收益率-扣除/加权-增长率(%)-20.363604.50450-4.1812
税前利润增长率(%)-10.368175.35313.150601.7549
扣除非经常性损益后净利润35501818.01--72654956.6957010115.142135246.08
成长能力分析
主营收入增长率(%)38.445950.21719.1964019.5973
净利润增长率(%)-24.56423.778-2.712209.8435
总资产增长率(%)19.17299.667.6452012.7369
股东权益增长率(%)5.15716.8726.5995010.3378
主营利润增长率(%)55.845174.79226.1612018.3314
财务结构分析
资产负债率(%)39.964735.4732.758629.52931.0083
长期负债资产比(%)8.43919.4817.438.99510.1844
固定比(%)46.907246.51547.776445.82445.2438
现金流量比率
主营收入现金含量(倍)1.14311.1131.144--1.2206
净利润现金含量(倍)0.47660.0610.6312--0.2931
恒瑞医药(600276) 财务指标
报告期2002-03-312001-12-312001-06-302000-12-312000-06-30
每股财务数据
每股收益(元)0.0860.3820.2020.4910.28
每股收益增长率(%)0-22.2907-26.77-11.13080
每股收益-扣除(元)--0.2960.1870.429--
每股收益-扣除-增长率(%)0-31.0023000
每股收益-加权(元)--0.3820.2020.635--
每股收益-加权-增长率(%)0-39.8425000
每股收益-扣除/加权(元)--0.2960.1870.56--
每股收益-扣除/加权-增长率(%)0-47.1429000
每股未分配利润(元)0.4860.39990.31960.48890.6592
每股可分配利润(元)--0.63740.50710.58890.6592
每股净资产(元)3.5863.4963.3565.0472.003
每股净资产增长率(%)0-30.729367.524192.07260
每股净资产-调整(元)--3.4593.3315.008--
每股现金含量(元)--0.0540.03550.14760.1082
每股资本公积金(元)1.8621.85741.8383.24070.0419
每股盈余公积金(元)0.2380.23840.19810.31690.302
每股负债比(%)187.325169.8505154.9791236.1356277.4751
偿债能力分析
流动比率2.5322.84293.75024.13741.44
速动比率2.262.49813.31563.63071.04
现金流动负债比(%)--4.76583.493610.32444.661
股东权益比(%)64.69866.402768.246267.976441.712
流动负债率(%)71.31966.762265.497960.533883.656
负债权益比(%)52.23548.587446.184546.7916138.5237
经营效率分析
存货周转天(天)115.237126.4045131.8005136.0647130.852
存货周转率(倍)0.7812.8481.36572.64581.36
应收款周转天(天)130.624114.660655.0391131.5261125.8213
应收帐款周转率(倍)0.6893.13971.80222.73711.69
主营成本比例(%)42.17440.265643.307146.772448.3124
营业费用比例(%)23.68426.580219.969923.064418.4012
管理费用比例(%)17.71316.876815.188513.41813.6286
财务费用比例(%)3.1781.68911.83821.22672.1189
总资产周转率(倍)0.1290.60250.29490.66860.5075
盈利能力分析
经营净利率(%)12.28812.795114.302113.466111.0722
经营毛利率(%)56.61158.503555.515252.197250.7197
资产利润率(%)1.6779.27816.266111.29498.4925
资产净利率(%)1.5877.70964.21829.00315.6194
净利润率(%)12.28812.795114.302113.466111.0722
净资产收益率(%)2.39110.926.0079.7413.74
净资产收益率-增长率(%)012.182-56.2869-69.57290
净资产收益率-扣除(%)--8.475.578.51--
净资产收益率-扣除-增长率(%)0-0.47000
净资产收益率-加权(%)--11.456.1921.07--
净资产收益率-加权-增长率(%)0-45.6573000
净资产收益率-扣除/加权(%)--8.885.7418.6--
净资产收益率-扣除/加权-增长率(%)0-52.2581000
税前利润增长率(%)019.268364.782930.57870
扣除非经常性损益后净利润--62949303.0939002157.2357032302.16--
成长能力分析
主营收入增长率(%)030.856129.784717.09890
净利润增长率(%)024.334967.644227.15420
总资产增长率(%)013.4598134.4009112.6930
股东权益增长率(%)010.8332283.51317.89810
主营利润增长率(%)046.665842.055630.7430
财务结构分析
资产负债率(%)33.79532.263331.519231.807257.78
长期负债资产比(%)9.69310.723610.874812.55319.4437
固定比(%)38.49938.254922.429220.178730.1044
现金流量比率
主营收入现金含量(倍)--1.08751.02831.15851.167
净利润现金含量(倍)--0.14150.17590.30040.3931
恒瑞医药(600276) 财务指标
报告期1999-12-311998-12-311997-12-31
每股财务数据
每股收益(元)0.550.70.66
每股收益增长率(%)-20.83815.2575--
每股收益-扣除(元)------
每股收益-扣除-增长率(%)------
每股收益-加权(元)------
每股收益-加权-增长率(%)------
每股收益-扣除/加权(元)------
每股收益-扣除/加权-增长率(%)------
每股未分配利润(元)0.38390.92690.3934
每股可分配利润(元)1.04730.92690.3934
每股净资产(元)1.72782.25751.5224
每股净资产增长率(%)-23.461548.2836--
每股净资产-调整(元)------
每股现金含量(元)0.365----
每股资本公积金(元)0.04190.06290.0262
每股盈余公积金(元)0.3020.26770.1028
每股负债比(%)324.362361.8678312.4016
偿债能力分析
流动比率1.251.310.86
速动比率0.960.810.49
现金流动负债比(%)12.8139----
股东权益比(%)34.597238.229432.6173
流动负债率(%)87.814580.74493.1249
负债权益比(%)187.7272160.2976205.2029
经营效率分析
存货周转天(天)138.9961138.4615134.3284
存货周转率(倍)2.592.62.68
应收款周转天(天)102.272776.595763.3803
应收帐款周转率(倍)3.524.75.68
主营成本比例(%)52.241756.519359.4224
营业费用比例(%)16.169715.279115.4931
管理费用比例(%)13.964111.49210.6004
财务费用比例(%)1.62772.54763.3158
总资产周转率(倍)0.99831.1118--
盈利能力分析
经营净利率(%)12.401211.883113.5292
经营毛利率(%)46.7542.622339.8152
资产利润率(%)15.125115.9323--
资产净利率(%)12.380713.2113--
净利润率(%)12.401211.883113.5292
净资产收益率(%)3230.9443.58
净资产收益率-增长率(%)3.4275-29.0161--
净资产收益率-扣除(%)------
净资产收益率-扣除-增长率(%)------
净资产收益率-加权(%)------
净资产收益率-加权-增长率(%)------
净资产收益率-扣除/加权(%)------
净资产收益率-扣除/加权-增长率(%)------